Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2000
03/01/2000CN1246155A Method for production of dicarboxylic acids
03/01/2000CN1246153A Mutant alpha-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus Licheniforms
03/01/2000CN1246152A Esterases, DNA encoding therefor and vectors and host cells incorporating same
03/01/2000CN1246149A Thermostable endo-beta-1,4-glucanase
03/01/2000CN1246148A Enlarged cellulase compositions for use in treatment of textiles
03/01/2000CN1246147A Enzymatic process for preparation of cephalosporanic 7 beta-(4-carboxybutanamide) acid by means of modified enzyme D-aminoacid oxidase of trigonopsis variabilis produced in escherichia coli
03/01/2000CN1246146A Chemically modified enzymes
03/01/2000CN1246113A Process for crystallization of reverse transcriptase inhibitor using anti-solvent
03/01/2000CN1245831A High temp. non-inactivation preparation method of superoxide dismutase
03/01/2000CN1245798A New hydroxamic acid compounds, their preparation method and medicine composition containing them
03/01/2000CN1245720A Medicinal composition containing calcineurin B subunit
02/2000
02/29/2000US6031156 Heterologous gene expression utilizing plant asparagine synthetase promoters
02/29/2000US6031155 Arabinoxylan degradation
02/29/2000US6031154 Fructokinase genes and their use in metabolic engineering of fruit sweetness
02/29/2000US6031087 Nucleotide sequences or complementary sequences of a type ii serine protease inhibitor precursor from a plant; for pathogen resistant transgenic plants
02/29/2000US6031082 Treating protein mixture solution with a solid adsorption material, crystallizing protein, harvesting crystals; for fermentation broth
02/29/2000US6030942 Peptides peptide analogs peptidomimetics and other small molecules useful for inhibiting the activity of ribonucleotide reductase
02/29/2000US6030940 Peptide analog inhibitors of urokinase receptor activity
02/29/2000US6030835 Methods and composition for identifying group a streptococcus
02/29/2000US6030834 Cdna (complementary dna) of human i kappa b kinase involved in activating transcription factors and causing inflammation; for drug screening of antiinflammatory agents
02/29/2000US6030826 Human parvulin-like protein
02/29/2000US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
02/29/2000US6030824 Human N-acetylneuraminate lyase
02/29/2000US6030823 For industrial production of d-amino acids from n-acetyl-d-amino acids
02/29/2000US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents
02/29/2000US6030821 Drying a solution comprising a microbial transglutaminase and an additional proteinaceous substance; for storage stable composition used in food processing which retains activity after 1 year at 24 degrees celsius
02/29/2000US6030819 Genetically engineered microorganisms and method for producing 4-hydroxybenzoic acid
02/29/2000US6030813 Phosphoramidate-phosphodiester oligonucleotide chimera utilized as primers
02/29/2000US6030809 Nucleotide and amino acid sequences; for diagnosis and treatment of cancer and immune disorders; antiproliferative agents; anticarcinogenic agents
02/29/2000US6030807 Nucleic acid from the bacillus substilis l-arabinose operon for gene expression in prokaryotic hosts; inducible with exogenous l-arabinose and repressible with exogenous glucose
02/29/2000US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents
02/29/2000US6030798 Method of identifying a lipase for treatment of digestive disorders
02/29/2000US6030791 For diagnosis, prevention and treatment of disease states or conditions associated with excessive tissue wasting
02/29/2000US6030788 Cyclin-dependent protein kinase
02/29/2000US6030785 Incubating a mixture containing pkr protein kinase, a viral protein containing an interferon sensitivity determining region, and an agent to be tested; then measuring the protein kinase activity where activity indicates an antiviral agent
02/29/2000US6030779 Screening for novel bioactivities
02/29/2000US6030776 Parallel SELEX
02/29/2000US6030771 Mosaic protein and restriction endonuclease assisted ligation method for making the same
02/29/2000US6030648 Extracts/cloud stability
02/29/2000US6030638 Plasmid for in vivo expression of prostaglandin synthase
02/29/2000US6030625 Bordetella pertussis and Bordetella parapertussis strains
02/29/2000US6030612 Antimicrobial uses of multifunctional enzyme
02/29/2000US6030611 Administering cuzn superoxide dismutase to organ recipient following transplantation
02/29/2000CA1340916C Method for enhancing production of secondary metabolites using clustered biosynthetic genes
02/29/2000CA1340915C Myeloperoxydase humaine et application therapeutique
02/26/2000CA2280675A1 Enhanced phosphorylation of p53 by atm in response to dna damage
02/24/2000WO2000009754A2 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS
02/24/2000WO2000009752A1 Cyp3a4 nfse variant and methods of use therefor
02/24/2000WO2000009744A1 Crystal structure of escherichia coli gdp-fucose synthetase and methods of its use
02/24/2000WO2000009739A1 Monoclonal antibody against canine trypsin
02/24/2000WO2000009736A1 α2,8/2,9 POLYSIALYLTRANSFERASE
02/24/2000WO2000009729A2 Expression of chitin synthase and chitin deacetylase genes in plants to alter the cell wall for industrial uses and improved disease resistance
02/24/2000WO2000009727A2 Dna shuffling to produce herbicide selective crops
02/24/2000WO2000009726A1 Transgenic trees having improved nitrogen metabolism
02/24/2000WO2000009725A2 Method for recovering proteins from the interstitial fluid of plant tissues
02/24/2000WO2000009724A1 Transgenic plants expressing a mapkkk protein kinase domain
02/24/2000WO2000009723A1 Maize rad6 genes and uses thereof
02/24/2000WO2000009722A2 Methods for controlling gibberellin levels
02/24/2000WO2000009721A1 Increasing stearate content in soybean oil by expression of acyl-acp thiosterase
02/24/2000WO2000009717A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence
02/24/2000WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
02/24/2000WO2000009710A2 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists
02/24/2000WO2000009709A2 Proteases and associated proteins
02/24/2000WO2000009708A1 Dna constructs comprising protease encoding sequences or inhibitors thereof
02/24/2000WO2000009707A1 Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same
02/24/2000WO2000009706A2 Maize cellulose synthases and uses thereof
02/24/2000WO2000009705A2 Selection method
02/24/2000WO2000009682A1 Dna shuffling of monooxygenase genes for production of industrial chemicals
02/24/2000WO2000009677A2 Sterol-regulated site-1 protease and assays of modulators thereof
02/24/2000WO2000009672A1 Dnazymes and methods for treating restenosis
02/24/2000WO2000009667A1 Calcineurin-dependent control of skeletal muscle fiber type
02/24/2000WO2000009663A1 Enhanced uptake and transport of plant nutrients and other elements
02/24/2000WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory
02/24/2000WO2000009656A2 Transgenic plants expressing a dual-specificity mapk phosphatase and uses thereof
02/24/2000WO2000009653A2 Method of inhibiting cathepsin k
02/24/2000WO2000009556A1 Human lysophospholipase gene (cbfblh05)
02/24/2000WO2000009543A2 Hepatitis c inhibitor tri-peptides
02/24/2000WO2000009542A1 SERINE PROTEASE INHIBITORS COMPRISING α-KETO HETEROCYCLES
02/24/2000WO2000009153A1 Compositions and methods for treating lysosomal storage disease
02/24/2000WO2000008920A1 Polynucleotides controlling the expression of and coding for gene b in tomato
02/24/2000WO2000003581A8 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity
02/24/2000WO2000001824A3 Method for genetic engineering of disease resistance using the drr206 class of proteins
02/24/2000WO2000001808A3 IN VIVO ADDITION OF TELOMERIC REPEATS TO EXOGENOUS DNA GENERATES EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS)
02/24/2000WO2000001804A3 Nucleotide sequence encoding a protein with beta glucanase activity and use thereof
02/24/2000WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors
02/24/2000WO1999060096A9 Oxygenase enzymes and screening method
02/24/2000WO1999058692A3 Human apoptosis associated proteins
02/24/2000WO1999058648A3 Guava (psidium guajava) 13-hydroperoxide lyase and uses thereof
02/24/2000WO1999055885A3 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
02/24/2000WO1999055857A3 Nucleoside triphosphates and their incorporation into ribozymes
02/24/2000WO1999051722A3 Recombinant l-n-carbamoylase derived from arthrobacter aurescens, and a method for producing l-amino acids by using the same
02/24/2000WO1999045127A3 Enhanced prodrug activation
02/24/2000WO1999043797A3 Constitutive maize promoters
02/24/2000DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis
02/24/2000DE19836774A1 Protein und DNA-Sequenz der Pinosylvin-3-0-methyltransferase (PMT) Protein and DNA sequence of the pinosylvin-3-0-methyltransferase (PMT)
02/24/2000CA2349852A1 Method for recovering proteins from the interstitial fluid of plant tissues
02/24/2000CA2340322A1 Dnazymes and methods for treating restenosis
02/24/2000CA2340074A1 Crystal structure of escherichia coli gdp-fucose synthetase and methods of its use
02/24/2000CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
02/24/2000CA2339524A1 Cyp3a4 nfse variant and methods of use therefor